Alyeska Investment Group
ORIC icon

Alyeska Investment Group’s Oric Pharmaceuticals ORIC Stock Holding History

Alyeska Investment Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Buy
+137,489
New +$1.56M ﹤0.01% 551
2021
Q4 		– Sell
-109,945
Closed -$2.3M – 696
2021
Q3 		$2.3M Sell
109,945
-175,000
-61% -$3.55M 0.03% 484
2021
Q2 		$5.04M Sell
284,945
-500
-0.2% -$11K 0.06% 341
2021
Q1 		$6.99M Buy
285,445
+36,547
+15% +$1.15M 0.09% 267
2020
Q4 		$8.43M Buy
248,898
+87,313
+54% +$2.51M 0.12% 218
2020
Q3 		$4.04M Hold
161,585
– – 0.06% 284
2020
Q2 		$5.45M Buy
+161,585
New +$5.16M 0.08% 259

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Alyeska Investment Group's ORIC Position: Q1 2026 in Review

Alyeska Investment Group opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 137,489 shares worth $1.74M. The stake represents ﹤0.01% of the portfolio and ranks #551 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in ORIC as recently as Q3 2021.

Alyeska Investment Group first reported a position in ORIC in Q2 2020 and has held it in 7 quarters since. The position peaked at $8.43M in Q4 2020. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Alyeska Investment Group held 137,489 shares of Oric Pharmaceuticals worth $1.74M as of Q1 2026.
  • Oric Pharmaceuticals was a new Alyeska Investment Group position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #551 holding.
  • Alyeska Investment Group first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 7 quarters since.
  • Alyeska Investment Group's Oric Pharmaceuticals position peaked at $8.43M in Q4 2020.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.